Brain Tumor Pathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q2 | 52.2% | 0.623 | Q2 | 69.0% |
| 2024 | 3.0 | Q2 | 70.0% | 0.611 | Q2 | 69.0% |
| 2023 | 2.7 | Q2 | 64.1% | 0.776 | Q2 | 78.8% |
| 2022 | 3.3 | Q2 | 62.3% | 0.804 | Q2 | 80.7% |
| 2021 | 3.2 | Q3 | 52.6% | 0.685 | Q2 | 76.8% |
| 2020 | — | — | 0.860 | Q2 | 81.7% | |
| 2019 | — | — | 0.956 | Q1 | 84.7% | |
| 2018 | — | — | 1.198 | Q1 | 87.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1861-387X
ISSN
1433-7398
country
SGcoverage
1997-2026